/
MBOT
$1.87+$0.10 (+5.65%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$118.9M
67M shares
52-week range
$1.60 – $4.67
9% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
2.16%
Moderate
Price (6 mo)
Loading chart…
Change$-6.05
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $54.0K | $84.0K | $0 | $0 | $0 | $106.0K | $91.0K | $0 |
| Gross profit | −$54.0K | −$84.0K | $0 | $0 | $0 | −$106.0K | −$91.0K | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $2.9M | $3.0M | $3.4M | $6.2M | $7.7M | $5.7M | $6.6M | $6.3M |
| Operating income | −$7.2M | −$7.2M | −$9.1M | −$11.4M | −$13.3M | −$9.9M | −$11.6M | −$14.7M |
| EBITDA | −$7.2M | −$7.1M | −$9.0M | −$11.2M | −$13.3M | −$10.6M | −$11.4M | −$13.1M |
| Net income | −$7.3M | −$7.2M | −$9.2M | −$11.3M | −$13.2M | −$10.7M | −$11.4M | −$13.1M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.81 | -1.70 | -1.29 | -1.59 | -1.81 | -1.05 | -0.73 | -0.29 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $5M | $-0.29 | $-0.30–$-0.28 | 2 |
| 2027 | $11M | $-0.32 | $-0.35–$-0.29 | 1 |
| 2028 | $24M | $-0.20 | $-0.23–$-0.18 | 2 |
| 2029 | $48M | $0.03 | $0.03–$0.03 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.07
Price
$1.87
Implied downside
-96%
Peer comparison
Microbot Medical, Inc. Common Stock
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
www.microbotmedical.com- Employees
- 22
- IPO / List date
- Mar 25, 1992
- HQ
- HINGHAM, MA
Held by traders on TradeandTell
No one on the platform currently holds MBOT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 24,560 | $49.1K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2018-09-05 | 1-for-15reverse |
| 2016-05-09 | 1-for-12reverse |
Recent trades on TradeandTell
No one on the platform has traded MBOT yet.
